Chip-based digital polymerase chain reaction technology is useful for monitoring the JAK2 V617F allele burden in Philadelphia-negative myeloproliferative neoplasms

被引：0
|
作者：
Furuya, Daisuke [1 ]
Moriai, Mikako [1 ]
Murai, Ryosei [1 ]
Moriai, Ryosuke [1 ]
Koizumi, Yuki [1 ]
Endo, Teruo [1 ]
Asanuma, Kouichi [1 ]
Yanagihara, Nozomi [1 ,2 ]
Takahashi, Satoshi [1 ,2 ]
机构：
[1] Sapporo Med Univ Hosp, Div Lab Med, Sapporo, Hokkaido, Japan
[2] Sapporo Med Univ, Sch Med, Dept Infect Control & Lab Med, Sapporo, Hokkaido, Japan
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2019年 / 41卷 / 05期
关键词：
REVISED RESPONSE CRITERIA; IWG-MRT; MUTATION; ELN;
D O I：
10.1111/ijlh.13013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E113 / E116
页数：4
相关论文
共 50 条
  • [1] JAK2 V617F ALLELE BURDEN AND VASCULAR COMPLICATION OCCURRENCE RISK IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
    Borowczyk, M.
    Lewandowski, K.
    Wojtaszewska, M.
    Gil, L.
    Lewandowska, M.
    Lehmann-Kopydlowska, A.
    Kroll-Balcerzak, R.
    Balcerzak, A.
    Iwola, M.
    Michalak, M.
    Komarnicki, M.
    HAEMATOLOGICA, 2014, 99 : 129 - 129
  • [2] Quantitative Analysis of JAK2 V617F Allele Burden Using a Chip-Based Digital PCR Technology
    Mai, M.
    Viswanatha, D. S.
    He, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 771 - 771
  • [3] Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms
    Yoenal-Hindilerden, Ipek
    Sahin, Ezgi
    Hindilerden, Fehmi
    Daglar-Aday, Aynur
    Nalcaci, Meliha
    TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 (03) : 174 - 182
  • [4] The JAK2 V617F mutation in Philadelphia-negative chronic myeloproliferative disorders
    Stoj, Anastazja
    Rudzki, Zbigniew
    Stachura, Jerzy
    Sacha, Tomasz
    Czekalska, Sylwia
    JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (09) : 1070 - 1071
  • [5] The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms
    Borowczyk, Martyna
    Wojtaszewska, Marzena
    Lewandowski, Krzysztof
    Gil, Lidia
    Lewandowska, Maria
    Lehmann-Kopydlowska, Agata
    Kroll-Balcerzak, Renata
    Balcerzak, Andrzej
    Iwola, Malgorzata
    Michalak, Michal
    Komarnicki, Mieczyslaw
    THROMBOSIS RESEARCH, 2015, 135 (02) : 272 - 280
  • [6] The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms
    Yonal-Hindilerden, Ipek
    Sahin, Ezgi
    Hindilerden, Fehmi
    Daglar-Aday, Aynur
    Nalcaci, Meliha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S338 - S338
  • [7] GLS in Philadelphia-negative and JAK2 V617F-driven myeloproliferative neoplasms (MPNs).
    Ciboddo, Michele
    Yan, George
    Coen, Chad
    Dowgielewicz, Jonathan
    Blaylock, Hunter
    Arellano, Nicole S.
    Zawieracz, Katarzyna
    Rosencrance, Alex
    Casetti, Ilaria C.
    Borsani, Oscar
    Catricala, Silvia
    Vanni, Daniele
    Saygin, Caner
    McNerney, Megan
    Faubert, Brandon
    Pietra, Daniela
    Rumi, Elisa
    Elf, Shannon Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] JAK2 V617F ALLELE BURDEN IN CHRONIC MYELOPROLIFERATIVE DISEASES
    Skerget, Matevz
    Pajic, Tadej
    Kralj, Eva
    Vuckovic, Josko
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 : I57 - I61
  • [9] Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms
    Gango, Ambrus
    Mozes, Reka
    Boha, Zsofia
    Kajtar, Bela
    Timar, Botond
    Kiraly, Peter Attila
    Kiss, Richard
    Fesus, Viktoria
    Nagy, Noemi
    Demeter, Judit
    Korosmezey, Gabor
    Borbenyi, Zita
    Marton, Imelda
    Szoke, Anita
    Masszi, Tamas
    Farkas, Peter
    Varkonyi, Judit
    Plander, Mark
    Posfai, Eva
    Egyed, Miklos
    Pal, Katalin
    Radvanyi, Gaspar
    Hamed, Aryan
    Csomor, Judit
    Matolcsy, Andras
    Alpar, Donat
    Bodor, Csaba
    LEUKEMIA RESEARCH, 2018, 65 : 42 - 48
  • [10] THROMBOTIC RISK ASSOCIATED WITH JAK2 V617F MUTATION AND INHERITED OR ACQUIRED THROMBOPHILIA IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
    Rossi, E.
    Betti, S.
    Za, T.
    Ciminello, A.
    Fresa, A.
    Bartolomei, F.
    Di Giovanni, A.
    Chiusolo, P.
    De Stefano, V.
    HAEMATOLOGICA, 2017, 102 : 97 - 97
12345